In Luo et al.’s study [48], FZD6 was identified as a potential biomarker for anaplastic thyroid cancer; FZD6 was also correlated with VEGFA expression, promoting vascularization and primary tumor spread in uveal melanoma [49]. This evidence concerns the gene FZD6 and thyroid gland undifferentiated (anaplastic) carcinoma.